Medichem is a vertically integrated pharmaceutical company. We specialize in the development and manufacture of APIs and FDFs for the global generics industry.

Our portfolio includes around 45 APIs and 20 FDFs, and we are a world leader read morein Chlorhexidine products.

We are headquartered in Spain, with a team of around 450 talented individuals in locations including the USA, Malta, and China. We serve over 600 corporate customers in more than 60 countries worldwide.

 

Minakem is a manufacturer of fine chemicals, pharmaceutical intermediates and (APIs). Today, the leading pharmaceutical and biopharmaceutical companies rely on Minakem’s strong technology platforms to manufacture high-profile proprietary compounds and develop innovative processes to add significant value within their supply chain.

Minakem has a long read moredistinguished history providing clients with cGMP intermediates, complex fine chemicals, API’s, Generics, contract services for the pharmaceutical and life science industries. Minakem operates three FDA approved sites in France and Germany. These facilities provide a full range of complementary technologies and services to the pharmaceutical industry for small, medium and large volumes of complex, regulated intermediates and APIs.

Moehs Group is a well established and reputated European API manufacturer and CMDO provider. Our company offers a solid platform for the development and production for third-parties of any kind of synthetic Small Molecules, either APIs or Intermediates.

Our Research Center starts development with few grams read morein the laboratory and progresses to batches of 1-2 Kg in the GMP certified Kilo lab and the range of 5-100Kg in our GMP Pilot Plant. Processes may be further scaled-up in our 7 European Manufacturing sites to hundreds of kilos batch size.

Our Research Center also offers development and manufacturing services of High Potent APIs from grams to 1-2Kg.

In terms of Analytical development and testing, our company offers analytical method development, validation and transfer services as long as GMP release testing. Our sites are equipped with the most state-of-the-art physico-chemical analytical equipment, including genotoxic impurities and nitrosamines testing.

All our sites are FDA approved, hold current EU GMP Certificate and run under a corporate common Quality Policy.

Supporting CMC services are also available. Our Regulatory Affairs team has experience on submissions all around the world, including EU, FDA, Brazil, China, Korea, among others.

Expert IP support is also available with internal resources for patent assessment and strategy.

MRIGlobal offers CDMO and CMC support services in Synthesis, Analytical, Stability and Logistical Support for Clinical Trial Materials. We provide GMP Services for Analytical, Stability and Logistical Support from pre-IND to post marketed drug products. In addition we have formulation capabilities and a Foreign Trade Zone to help read moremove materials into a secure environment in the USA in lieu of an IND that is not complete.